Intrinsic Value of S&P & Nasdaq Contact Us

Daxor Corporation DXR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
89/100
6/7 Pass
SharesGrow Intrinsic Value
$39.98
+326.2%
Analyst Price Target
$23.00
+145.2%

Daxor Corporation (DXR) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.

The consensus price target is $23.00, representing an upside of 145.2% from the current price $9.38.

Analysts estimate Earnings Per Share (EPS) of $0.08 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.11 vs est $0.08 (beat +37.5%). 2025: actual $1.84 vs est $0.08 (beat +2200%). Analyst accuracy: 39%.

DXR Stock — 12-Month Price Forecast

$23.00
▲ +145.20% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Daxor Corporation, the price target is $23.00.
The average price target represents a +145.20% change from the last price of $9.38.

DXR Analyst Ratings

Buy
3
Ratings
3 Buy
Based on 3 analysts giving stock ratings to Daxor Corporation in the past 3 months
Rating breakdown
Buy
3 100%
100%
Buy
3 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — DXR

39%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.11 vs Est $0.08 ▲ 27.3% off
2025 Actual $1.84 vs Est $0.08 ▲ 95.7% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.

Revenue Estimates — DXR

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.002B vs Est $0.002B ▼ 7.1% off
2025 Actual $0.001B vs Est $0.002B ▼ 353.2% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message